Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
QueueDr
AddedFeb 16, 2024
UpdatedJun 18, 2026
QueueDr

QueueDr

Acquired

QueueDr, a Phreesia company, is a leading healthcare software automating patient appointment scheduling and rescheduling.

HQ
San Francisco, CA, US
Founded
2013
Overview
Compare
Fundraising
Employees
Website

QueueDr, founded with the mission to revolutionize patient access in healthcare, developed a software solution that automates the scheduling and rescheduling of patient appointments. The core vision was to enhance patient-provider interactions by minimizing wait times and optimizing appointment slots. QueueDr's innovative technology allowed patients to fill missed appointments simply by responding to a text message, significantly reducing wait times and improving healthcare efficiency. The company primarily focused on serving top healthcare systems across the United States.

In 2021, QueueDr was acquired by Phreesia, a prominent player in patient intake management. This acquisition led to the rebranding of QueueDr's solution as Phreesia Appointment Accelerator. Notable achievements include helping patients avoid 3,000 years of cumulative waiting time in 2018 alone. The impact of QueueDr's technology has been profound, streamlining operations for healthcare providers and enhancing patient access to timely care.

QueueDr - Similar Companies

Phreesia logo

Phreesia

phreesia.com

Queues logo

Queues

queues.com

ZeroIn logo

ZeroIn

Queue logo

Queue

usequeue.com

DocClocker logo

DocClocker

docclocker.com

Waitwhile logo

Waitwhile

waitwhile.com

Navimize logo

Navimize

navimize.com

NexHealth logo

NexHealth

nexhealth.com

Doctible logo

Doctible

doctible.com

GetDoctor logo

GetDoctor

getdoctor.co

ReSchedule Med logo

ReSchedule Med

CareStack logo

CareStack

carestack.com

CaseCTRL logo

CaseCTRL

casectrl.com

Doc-Quick logo

Doc-Quick

Waitsup logo

Waitsup

QueueDr - Quick Facts

Who are QueueDr's competitors?

Companies similar to QueueDr include Phreesia, Queues, ZeroIn and Queue.

When was QueueDr founded?

QueueDr was founded in 2013.

Where is QueueDr's headquarters located?

QueueDr's headquarters is located in San Francisco, CA, US.

When was QueueDr's last funding round?

QueueDr's most recent funding round was for $1.2M (USD) in September 2016.

How much has QueueDr raised to-date?

As of Sep 28, 2016, QueueDr has raised a total of $1.2M (USD).

QueueDr - Classification

Ownership
  • Equity
  • Venture Capital
Technology
  • AI
  • Automation
Geographic Exposure
  • Americas
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
  • Small Business
Main Product
  • Healthcare Software
Tags
  • Healthtech
  • SaaS
NAICS
  • 513200Software Publishers
  • 510000Information
  • 513000Publishing Industries
  • 513210Software Publishers
SIC
  • 7300Business Services
  • 7370Computer Programming, Data Processing, And Other Computer Related
  • 7372Prepackaged Software